China · 
What does TF Capital invest in?
TF Capital invests most often at Series A and Series B (83% of the rounds on record), in sectors such as Biotech and Biopharmaceutical.
TF Capital highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series A and Series B: 83% of its rounds
What they do
The first and most significant money for innovative biotech in ChinaFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- BiotechBiopharmaceutical
- Based in
- Shanghai, China
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first6 appearances
- 2026
1 round
- May
- 2019
2 rounds
- Dec
- May
- 2015
1 round
- Apr
- 2014
2 rounds
- Dec
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
AMAbhishek MalikManager of the Manager of the FundiFiling they signed
CCChiang Chen Hsiu-LienDirectoriFiling they signed
JMJames Matin-LewisManageriFiling they signed
We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$618Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- TF Venture Capital Management Co., LTD.
- SEC number
- CRD 323481
What they claim to have backed
From their own portfolio page (on their website)
7 of 18 we have independently watched raise
AbbiskoAntengeneAsierisGempharmatechGenfleetHenliusHuamedicineCanbridgepharmaDreamcisFrontagelabGenorbioInnostarPegbioPharmaresources-usRdbioSanyoumedSmo-clinplusZailaboratory
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.